Miravo Healthcare™ Presents at the SNN Network Canada Virtual Event

- Wednesday, December 8th – 11:00 a.m. ET -

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Nuvo Pharmaceuticals^® Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, will be presenting at the SNN Network Canada Virtual Event 2021 on Wednesday, December 8, 2021 at 11:00 a.m. ET. Jesse Ledger, President & Chief Executive Officer and Mary-Jane Burkett, Vice President & Chief Financial Officer of Miravo will be hosting the presentation and answering questions from investors.

To access the live presentation, please use the following information:

SNN Network Canada Virtual Event 2021

Date: Wednesday, December 8, 2021
Time: 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time)
Webcast: https://www.webcaster4.com/Webcast/Page/2813/43693

If you would like to book 1on1 investor meetings with Miravo Healthcare, and to watch Miravo Healthcare’s presentation, please make sure you are registered for the virtual event here: https://canada.snn.network/signup.

1on1 meetings will be scheduled and conducted via private, secure video conference through the conference event platform.

The SNN Network Canada Virtual Event website is available here: https://canada.snn.network/.

If you can’t make the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”: https://canada.snn.network/agenda.

About Miravo Healthcare
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.miravohealthcare.com.

About SNN.Network
SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN Network.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211124005840/en/

Investor Relations

Stefan Eftychiou

905 326 1888 ext 60

stefan@bristolir.com

Source: Nuvo Pharmaceuticals Inc